NASDAQ:ARNA - Arena Pharmaceuticals SEC Filings & 10K Form

$62.29
+0.47 (+0.76 %)
(As of 07/22/2019 04:00 PM ET)
Today's Range
$62.25
Now: $62.29
$63.43
50-Day Range
$53.01
MA: $58.30
$62.35
52-Week Range
$31.97
Now: $62.29
$63.48
Volume345,923 shs
Average Volume494,668 shs
Market Capitalization$3.09 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.48

SEC Filings

Arena Pharmaceuticals (NASDAQ:ARNA) SEC Filings

DateFilerForm TypeView
06/20/2019
5:59 PM
Arena Pharmaceuticals (Issuer)
Lisicki Robert (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
06/17/2019
5:56 PM
Arena Pharmaceuticals (Issuer)
WOODS RANDALL E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/17/2019
5:53 PM
Arena Pharmaceuticals (Issuer)
Soni Manmeet Singh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/17/2019
5:51 PM
Arena Pharmaceuticals (Issuer)
Nova Tina Susan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/17/2019
5:48 PM
Arena Pharmaceuticals (Issuer)
NEIL GARRY ARTHUR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/17/2019
5:46 PM
Arena Pharmaceuticals (Issuer)
Jarrett Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/17/2019
5:43 PM
Arena Pharmaceuticals (Issuer)
GALLAHUE KIERAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/17/2019
5:41 PM
Arena Pharmaceuticals (Issuer)
FETZER OLIVER (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/17/2019
5:38 PM
Arena Pharmaceuticals (Issuer)
Dallas Jayson Donald Alexander (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/14/2019
3:51 PM
Arena Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
View Filing
06/14/2019
3:16 PM
Arena Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/09/2019
3:19 PM
Arena Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
05/08/2019
3:05 PM
Arena Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
04/30/2019
8:15 AM
Arena Pharmaceuticals (Filer)
Form DEFA14A
View Filing
04/30/2019
8:00 AM
Arena Pharmaceuticals (Filer)
Form DEF 14A
View Filing
03/20/2019
12:11 PM
Arena Pharmaceuticals (Filer)
Form CT ORDER
View Filing
03/08/2019
5:15 PM
Arena Pharmaceuticals (Issuer)
Nova Tina Susan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/14/2019
4:22 PM
Arena Pharmaceuticals (Subject)
Partner Fund Management, L.P. (Filed by)
Form SC 13G/A
View Filing
02/11/2019
8:32 AM
Arena Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
View Filing
02/04/2019
6:35 PM
Arena Pharmaceuticals (Issuer)
SPECTOR STEVEN W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/04/2019
9:07 AM
Arena Pharmaceuticals (Subject)
BlackRock Inc. (Filed by)
Form SC 13G/A
View Filing
01/25/2019
8:31 AM
Arena Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
01/10/2019
3:26 PM
Arena Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
01/10/2019
8:37 AM
Arena Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
View Filing
01/08/2019
8:04 PM
Arena Pharmaceuticals (Issuer)
Klassen Preston (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/08/2019
8:02 PM
Arena Pharmaceuticals (Issuer)
SPECTOR STEVEN W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/08/2019
8:01 PM
Arena Pharmaceuticals (Issuer)
Aurentz Vincent (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/08/2019
8:00 PM
Arena Pharmaceuticals (Issuer)
Lind Kevin Robert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/08/2019
7:58 PM
Arena Pharmaceuticals (Issuer)
Munshi Amit (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/07/2019
7:52 AM
Arena Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
12/17/2018
3:25 PM
Arena Pharmaceuticals (Issuer)
Soni Manmeet Singh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/17/2018
3:20 PM
Arena Pharmaceuticals (Issuer)
Soni Manmeet Singh (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
12/17/2018
3:15 PM
Arena Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
12/10/2018
8:24 AM
Arena Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
11/15/2018
7:12 AM
Arena Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
11/13/2018
9:38 AM
Arena Pharmaceuticals (Subject)
FMR LLC (Filed by)
Form SC 13G/A
View Filing
11/08/2018
3:11 PM
Arena Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
11/07/2018
3:04 PM
Arena Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
10/04/2018
7:03 AM
Arena Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
10/02/2018
3:05 PM
Arena Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
09/24/2018
3:11 PM
Arena Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
08/27/2018
3:03 PM
Arena Pharmaceuticals (Subject)
Partner Fund Management, L.P. (Filed by)
Form SC 13G
View Filing
08/17/2018
4:17 PM
Arena Pharmaceuticals (Issuer)
SPECTOR STEVEN W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
08/09/2018
9:21 AM
Arena Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
08/06/2018
3:01 PM
Arena Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
07/17/2018
8:15 AM
Arena Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
07/10/2018
3:14 PM
Arena Pharmaceuticals (Issuer)
GALLAHUE KIERAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
07/10/2018
3:12 PM
Arena Pharmaceuticals (Issuer)
GALLAHUE KIERAN (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
07/10/2018
3:08 PM
Arena Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
06/15/2018
3:35 PM
Arena Pharmaceuticals (Issuer)
WOODS RANDALL E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/15/2018
3:34 PM
Arena Pharmaceuticals (Issuer)
Nova Tina Susan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/15/2018
3:32 PM
Arena Pharmaceuticals (Issuer)
NEIL GARRY ARTHUR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/15/2018
3:31 PM
Arena Pharmaceuticals (Issuer)
Jarrett Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/15/2018
3:30 PM
Arena Pharmaceuticals (Issuer)
FETZER OLIVER (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/15/2018
3:29 PM
Arena Pharmaceuticals (Issuer)
Dallas Jayson Donald Alexander (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/14/2018
4:27 PM
Arena Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/09/2018
3:06 PM
Arena Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
05/08/2018
3:02 PM
Arena Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
04/30/2018
3:05 PM
Arena Pharmaceuticals (Filer)
Form DEF 14A
View Filing
04/18/2018
4:31 PM
Arena Pharmaceuticals (Issuer)
SPECTOR STEVEN W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
04/10/2018
9:11 AM
Arena Pharmaceuticals (Subject)
FMR LLC (Filed by)
Form SC 13G/A
View Filing
04/02/2018
6:00 AM
Arena Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
03/22/2018
3:10 PM
Arena Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
03/22/2018
3:07 PM
Arena Pharmaceuticals (Filer)
Form 424B5
View Filing
03/20/2018
4:28 PM
Arena Pharmaceuticals (Filer)
Form 424B5
View Filing
03/19/2018
3:10 PM
Arena Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
03/14/2018
4:26 PM
Arena Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
View Filing
03/14/2018
7:05 AM
Arena Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
03/12/2018
5:03 AM
Arena Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
03/06/2018
6:30 PM
Arena Pharmaceuticals (Issuer)
SPECTOR STEVEN W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/16/2018
8:00 AM
Arena Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
02/14/2018
3:54 PM
Arena Pharmaceuticals (Subject)
GREAT POINT PARTNERS LLC (Filed by)
Form SC 13G/A
View Filing
02/13/2018
8:33 AM
Arena Pharmaceuticals (Subject)
FMR LLC (Filed by)
Form SC 13G
View Filing
02/12/2018
7:28 AM
Arena Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
View Filing
01/29/2018
3:40 PM
Arena Pharmaceuticals (Subject)
BlackRock Inc. (Filed by)
Form SC 13G
View Filing
01/22/2018
4:32 PM
Arena Pharmaceuticals (Issuer)
SPECTOR STEVEN W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/22/2018
4:31 PM
Arena Pharmaceuticals (Issuer)
Aurentz Vincent (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/22/2018
4:30 PM
Arena Pharmaceuticals (Issuer)
Klassen Preston (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/22/2018
4:28 PM
Arena Pharmaceuticals (Issuer)
Lind Kevin Robert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/22/2018
4:27 PM
Arena Pharmaceuticals (Issuer)
Munshi Amit (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/22/2018
4:25 PM
Arena Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
01/08/2018
9:30 AM
Arena Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
01/05/2018
4:08 PM
Arena Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
12/19/2017
5:00 PM
Arena Pharmaceuticals (Issuer)
SPECTOR STEVEN W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/05/2017
7:35 AM
Arena Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
This page was last updated on 7/22/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel